Skip to content
metsa.jpeg

Life Cycle Assessment of Orion's Transdermal Gel Used in Hormone Replacement Therapy (HRT)

This summary provides an overview to a cradle-to-grave life cycle assessment (LCA) of Orion Pharma’s estradiol 0.1 % transdermal gel conducted in 2026. This summary includes only climate-related impacts.

The global warming potential (GWP, carbon footprint) of 1 gram of estradiol 0.1 % transdermal gel ranges from 4.5 to 9.4 gCO₂e, depending on the packaging type and size.

Life Cycle Assessment of estradiol 0.1 % transdermal gel. Orion & UseLess Company Oy 2026.

Summary of the study